| Cash and cash equivalents |
47.17K |
| Accounts receivable |
| Inventory (Note 5) |
| Other current assets (Note 12) |
8.1K |
| Total Current Assets |
55.27K |
| Property and Equipment, Net |
1.75K |
| Assets Held for Investment, Net |
| Patents, Net |
1.24M |
| TOTAL ASSETS |
1.29M |
| Accounts payable and accrued expenses (Note 6) |
8.73M |
| Deferred revenue |
| Current maturities of long-term debt |
| Total Current Liabilities |
8.73M |
| Long-Term Debt, Net |
| Derivative Warrant Liability (Note 11) |
1.28M |
| Derivative Additional Investment Rights Liability (Note 11) |
158.89K |
| Total Liabilities |
10.17M |
| Commitments and Contingencies (Notes 7 and 8) |
| Stockholders' Deficiency (Note 10): |
| Common stock, $.001 par value; authorized 750,000,000 shares at April 30, 2012 and July 31, 2011, respectively; 346,678,800 and 308,519,768 shares issued and outstanding at April 30, 2012 and July 31, 2011, respectively |
903.33K |
| Additional paid-in capital |
362.77M |
| Deficit accumulated during the development stage |
| Accumulated other comprehensive income |
787.96K |
| Total Stockholders' Deficiency |
-8.88M |
| TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY |
1.29M |
| Stockholders' Deficiency (Note 10): |
| Preferred Stock Value |
0 |
| Stockholders' Deficiency (Note 10): |
| Preferred Stock Value |
0 |
